Cost variation study of different bands of psychiatric drugs available in Indian market with reference to Indian drug price control order

2020 ◽  
pp. 1
Author(s):  
Anand Dixit ◽  
Dinesh Meena
Keyword(s):  
Drug Price ◽  
Price Control ◽  
Indian Market ◽  
Cost Variation ◽  
Psychiatric Drugs ◽  
Control Order

scholarly journals Cost comparison of commonly used antidepressant drugs with drug price control order in India

2019 ◽  
Vol 9 (1) ◽  
pp. 186
Author(s):  
Narendra Kumar ◽  
Alisha Abbas ◽  
Akhlaque Ahmad ◽  
Reshma Choudhary ◽  
Arpan Ganguly ◽  
...  
Keyword(s):  
Drug Price ◽  
Antidepressant Drugs ◽  
Price Control ◽  
Cost Comparison ◽  
Pharmaceutical Companies ◽  
Indian Market ◽  
Pharmaceutical Pricing ◽  
Ceiling Price ◽  
Strict Regulation ◽  
Control Order

Background: Price of a drug is an important factor for compliance to the treatment. So, to overcome the high prices of drugs, National Pharmaceutical Pricing Authority (NPPA) under government of India has issued Drug Price Control Order (DPCO) list containing commonly used drugs. Pharmaceutical companies can be punished if they keep their prices higher than the ceiling price mentioned in the DPCO. To find out the price variations of commonly used antidepressant drugs included in DPCO list of 29th April 2019.Methods: A list of all oral antidepressant drugs included in DPCO of 29th April 2019 and available in Indian market was procured from medguide India. Analysis of number of total brands following as well as not following DPCO ceiling price was done.Results: Author found 17 formulations of four antidepressant drugs included in DPCO. Total 556 brands found out of which 84.6% were following the DPCO and 15.4% of brands prices were higher than the ceiling price of DPCO.Conclusions: Though large number of companies are following the DPCO but still strict regulation is needed to further increase the compliance of guidelines.

scholarly journals Drug price control order: the impact on pharmacoeconomics

2019 ◽  
Vol 8 (10) ◽  
pp. 2220
Author(s):  
Suchi M. Shah ◽  
Anil P. Singh ◽  
Parth K. Vachhani
Keyword(s):  
Drug Therapy ◽  
Drug Price ◽  
Price Control ◽  
Medical Specialties ◽  
Retail Prices ◽  
The Difference ◽  
Control Order ◽  
Microsoft Office ◽  
The Cost ◽  
The Impact

Background: The objective of the present study was to analyze the prices of metformin, losartan, atorvastatin, paracetamol and aspirin for the doses which are included in the list of Drug Price Control Order (DPCO) 2013.Methods: Current index medical specialties India, 37th year, April-July 2015 issue was used for analysis. The retail prices of the drugs in INR were tabulated in Microsoft Office Excel 2013. The prices of the above listed drugs were compared with prices of DPCO 2013 for the same doses of drugs. The analysis of drugs costing more than the prices listed in the DPCO with the margin of the difference in percentage was carried out.Results: Out of 25 brands of metformin 500 mg tablet, 11 (44%) brands had price higher than listed in DPCO 2013. Similarly, prices for losartan 25 mg and 50 mg tablets, 8 (25%) out of 32 and 11 (31.42%) out of 35 were higher respectively. For atorvastatin 5 mg and 10 mg tablets, 2 (9.52%) out of 21 and 8 (13.55%) out of 59 brands had higher prices. For paracetamol 500 mg tablet, 12 (63.15%) out of 19 brands were priced higher than DPCO list. For aspirin 100 mg tablet and 325 mg tablet, 3 (100%) out of 3 brands and 1 (100%) out of 1 brand had higher prices.Conclusions: Many of the brand formulations have higher prices than the DPCO 2013 issued by government of India. The clinicians prescribing these drugs should be aware of these brand formulations to reduce the cost of the drug therapy.

scholarly journals A Cost Variation Analysis of Drugs Available in the Indian Market for the Management of Thromboembolic Disorders

Cureus ◽  
2020 ◽  
Author(s):  
Avik Ray ◽  
Ahmad Najmi ◽  
Gaurav Khandelwal ◽  
Balakrishnan Sadasivam
Keyword(s):  
Variation Analysis ◽  
Indian Market ◽  
Cost Variation

scholarly journals The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals

2005 ◽  
Vol 20 (3) ◽  
pp. 185-196 ◽  
Author(s):  
Qingyue Meng ◽  
Gang Cheng ◽  
Lynn Silver ◽  
Xiaojie Sun ◽  
Clas Rehnberg ◽  
...  
Keyword(s):  
Drug Price ◽  
Control Policy ◽  
Price Control ◽  
Hospital Expenditures ◽  
The Impact

scholarly journals Cost variation analysis of various brands of anti-epileptic drugs currently available in Indian pharmaceutical market

2017 ◽  
Vol 6 (7) ◽  
pp. 1666
Author(s):  
Saiyadali A. Allisabanavar ◽  
Narayana Reddy S.
Keyword(s):  
Low Cost ◽  
Indian Market ◽  
10Mg Tablet ◽  
Price Variation ◽  
Average Percentage ◽  
50Mg Tablet ◽  
Cost Variation ◽  
Anti Epileptic Drug ◽  
150Mg Tablet ◽  
The Cost

Background: Epilepsy is a common neurological disorder affecting about 10 million persons in India. The compliance to a particular antiepileptic drug is highly dependent on the cost of the drug which directly translates into success or failure of therapy. Hence there is a need for all clinicians to keep themselves updated with the latest prices and price variation of the commonly prescribed drugs. This study aims to analyze cost variation of various brands of anti-epileptic drugs currently available in Indian pharmaceutical market.Methods: Current Index of Medical Specialities July-October 2016 edition was referred to know the maximum and minimum price in INR of various brands of anti- epileptic drugs in India. Further analysis was done by using Percentage Cost Variation.Results: There is wide variation in the prices of different brands of same antiepileptic agents in Indian market. The highest % cost variation was found for diazepam 5mg tablet (374.42), followed by lorazepam 2mg tablet (213.63), carbamazepine 100mg syrup/5ml-100ml (172.58), levetiracetam 1000mg FC-tablet (168.57), lamotrigine 25mg DIS- tablet (150), clobazam 10mg tablet (147.37), clonazepam 0.5mg tablet (145.90), oxcarbazepine 150mg tablet (89.46), gabapentin 300mg capsule (71.67), valproic acid 200mg FC-tablet (58.62), divalproex sodium 500mg ER-tablet (47.82), topiramate 50mg tablet (41.66) and lowest % cost variation was of phenytoin sodium 300mg tablet (0.23).Conclusions: The average percentage price variation of different brands of same oral anti-epileptic drug in Indian market is very wide. To counter act such cost variation, physicians should be encouraged to prescribe a medication brand with low cost. This in turn reduces the unnecessary economic burden to the patients.

scholarly journals Cost variation among anxiolytic drugs

2018 ◽  
Vol 7 (3) ◽  
pp. 405
Author(s):  
Ajay Kumar Shukla ◽  
Neelesh Arya
Keyword(s):  
Anxiety Disorders ◽  
Term Treatment ◽  
Mental Illnesses ◽  
Variable Cost ◽  
Cost Ratio ◽  
Indian Market ◽  
Medical Specialties ◽  
Cost Variation ◽  
Long Term Treatment ◽  
Anxiolytic Drugs

Background: Indian pharmaceuticals market stands third and thirteenth largest in terms of value and volume in the Global Pharmaceutical Industry respectively. Anxiety disorders are one of the most common mental illnesses affecting more than 15% of the population at some point in their life span. Treatment of anxiety disorders usually follows a long term treatment. Cost of the treatment is an important factor determining the adherence to the treatment.Methods: Data relevant to various brands of anxiolytic drug available in the Indian market particular drug obtained from “Current Index of Medical Specialties” (CIMS) October 2017 - January 2018 was used to calculate the cost ratio and percentage cost variation.Results: There are 16 anxiolytic drugs in the form of 44 different formulations and 384 brands available in the Indian market. Among anxiolytic drugs, highest cost ratio and percent cost variation is for diazepam 5mg, followed by alprazolam 1mg and hydroxyzine 10mg. Highest number of brands of anxiolytic drugs available in Indian market are for clonazepam 0.5mg followed by alprazolam 0.5mg and escitalopram 10mg.Conclusions: In Indian market, there is availability of large number of brands with wide and variable cost variations among the various brands of the anxiolytic drugs.

Sign in / Sign up

Export Citation Format

Share Document